Skip to content

The esthetic, surgical, and oncological outcomes of immediate prosthesis-based breast reconstruction: a prospective cohort study

The esthetic, surgical, and oncological outcomes of immediate prosthesis-based breast reconstruction: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048040
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group 1:Subpectoral prosthetic reconstruction covered with with pectoralis major and TiLOOP? mesh
Group 2:Subpectoral prosthetic reconstruction covered with with pectoralis major and conjoined fascial flaps
Group 3:Subpectoral prosthetic reconstruction covered with with pectoralis major and other muscular tissues

Sponsors

Tianjin Cancer Hospital and Institute
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients treated with nipple-sparing or skin-sparing mastectomy; 2. Patients treated with immediate prosthetic breast reconstruction following mastectomy; 3. Patients with breast cancer should not have concurrent metastatic diseases; 4. Patients without concurrent or previous history of malignant tumors, except well-treated in situ diseases; 5. Patients who understand the purposes of this trial and are willing to sign inform consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients previously treated with mastectomy and receiving delayed breast reconstructions; 2. Other circumstances that are not suitable for participation in this study considered by the investigators.

Design outcomes

Primary

MeasureTime frame
aesthetic outcome;ratio of post-operative complications;Local-regional recurrence-free survival (LRFS);disease-free survival (DFS);Overall Survival (OS);

Countries

China

Contacts

Public ContactCao Xuchen, Zhang Bin

Tianjin Cancer Hospital and Institute

eeflying@163.com+86 18622228636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026